Effect of ACE/NEP inhibition on cardiac and vascular collagen in stroke-prone spontaneously hypertensive rats

American Journal of Hypertension

Volumn 14, Issue 10, 2001, Pages 1067-1072

  Pu, Qian ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Blood vessels; Fibrosis; Hypertension; Myocardium; Natriuretic peptides; SHRSP; Vasopeptidase

Indexed keywords

COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENKEPHALINASE INHIBITOR; MEMBRANE METALLOENDOPEPTIDASE; OMAPATRILAT;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; FIBROSIS; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; COLLAGEN; DISEASE MODELS, ANIMAL; FIBROSIS; HYPERTENSION; MYOCARDIUM; NEPRILYSIN; PYRIDINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; THIAZEPINES; VENTRICULAR REMODELING;

EID: 0034774067     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(01)02157-4     Document Type: Article

References (42)

1. Connective tissue: A metabolic entity?
2. Myocardial collagen remodeling in pressure overload hypertrophy. A case for interstitial heart disease
3. Remodeling of the rat right and left ventricles in experimental hypertension
4. Cardiac fibrosis and inflammation: Interaction with hemodynamic and hormonal factors
5. Hormonal regulation of cardiac fibroblast function
6. The regulation of collagen deposition in the hypertrophying heart
7. Raised blood pressure, not renin-angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats
8. Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats
9. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat
10. A receptor antagonism
11. Cardiac fibrosis in mice lacking brain natriuretic peptide
12. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts
13. Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression
14. Potentiation of natriuretic peptides by neutral endopeptidase inhibitors
15. Vasopeptidase inhibition
16. Long-term effects of brief antihypertensive treatment on systolic blood pressure and vascular reactivity in young genetically hypertensive rats
17. Chronic central administration of enalaprilat lowers blood pressure in stroke-prone spontaneously hypertensive rats
18. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats
19. Decreased content in left atrium and increased plasma concentration of atrial natriuretic polypeptide in spontaneously hypertensive rats (SHR) and SHR stroke-prone
20. Free and bound forms of atrial natriuretic peptide (ANP) in rat plasma: Preferential increase of free ANP in spontaneously hypertensive rats (SHR) and stroke-prone SHR (SHRSP)
21. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase in rats with hypertension
22. Effects of omapatrilat in low, normal, and high renin experimental hypertension
23. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure
24. Chronic dual inhibition of angiotensin-converting enzyme and neutral endopeptidase during the development of left ventricular dysfunction in dogs
25. Vasopeptidase inhibition has potent effects on blood pressure and resistance arteries in stroke-prone spontaneously hypertensive rats
26. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure
27. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: A potential therapeutic approach in hypertension
28. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension
29. Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHR
30. Atrial natriuretic polypepfide inhibits hypertrophy of vascular smooth muscle cells
31. Antagonism between the vascular renin-angiotensin and natriuretic peptide systems in vascular remodelling
32. Metabolism of bradykinin by the rat coronary vascular bed
33. Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide
34. Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11
35. Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension
36. Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease
37. Vascular endothelin-1 expression and effect of an endothelin ETA antagonist on structure and function of small arteries from stroke-prone spontaneously hypertensive rats
38. Endopeptidase 24.11 inhibition by SCH 42495 in essential hypertension
39. Modulation of functionally active endothelin-converting enzyme by chronic neutral endopeptidase inhibition in experimental atherosclerosis
40. Antihypertensive effects of the neutral endopeptidase inhibitor SCH 42495 in essential hypertension
41. Effect of angiotensin II on myocardial collagen gene expression
42. Angiotensin II type 1 receptor blockade prevents cardiac remodeling in bradykinin B(2) receptor knockout mice